← Back to Clinical Trials
Recruiting NCT07486193

NCT07486193 Effects of Nunchaku Exercise for Improving Frozen Shoulder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07486193
Status Recruiting
Phase
Sponsor Chinese University of Hong Kong
Condition Adhesive Capsulitis
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-04-14
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Shoulder Mobilization and Stretching Exercise (SMSE)Nunchaku Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-04-14 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to investigate if nunchaku exercise works to treat adhesive capsulitis, or frozen shoulder in middle-aged or older adults. It will also learn about the adherence of this exercise intervention. The main questions it aims to answer are: * Does practicing nunchaku exercises help reduce shoulder pain and improve shoulder movement? * Do people stick with nunchaku exercises better, and spend more time practicing on their own, compared with standard exercises for alleviating frozen-shoulder? Researchers will compare nunchaku exercise to standard exercises for alleviating frozen-shoulder to see if nunchaku exercise works to alleviate frozen shoulder. Participants will: * Join small group exercise classes for 12 weeks, doing either nunchaku based exercises or standard exercises designed to help relieve frozen shoulder. * Have their shoulder pain and movement checked three times: * before training * after 6 weeks of training, * after finishing the 12 week program, and * 12 weeks after the program ends. * Keep a record of their home practice time.

Eligibility Criteria

Inclusion Criteria: * Ethnic Chinese; * Age 45 years or above; * Diagnosed with Adhesive Capsulitis (Frozen Shoulder) and currently in the thawing stage. Exclusion Criteria: * Presence of secondary causes of shoulder stiffness, including recent trauma, post-surgical stiffness, or structural lesions such as full-thickness rotator cuff tears or severe glenohumeral arthritis; * Receipt of recent shoulder treatments known to influence short-term outcomes, including corticosteroid injections within the past three months, hydrodilatation, manipulation under anesthesia, arthroscopic capsular release within the past six months, or structured shoulder physiotherapy within the past three months; * Presence of somatic conditions that limit their ability to participate safely in exercise (e.g., inability to walk without an assistive device).

Contact & Investigator

Central Contact

Angus Pak-Hung Yu, PhD

✉ phayu@cuhk.edu.hk

📞 (852) 39435253

Frequently Asked Questions

Who can join the NCT07486193 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07486193 currently recruiting?

Yes, NCT07486193 is actively recruiting participants. Contact the research team at phayu@cuhk.edu.hk for enrollment information.

Where is the NCT07486193 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07486193 clinical trial?

NCT07486193 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology